Skip to main content

ADVERTISEMENT

Robert Jan van Geuns, MD, PhD

Original Contribution
07/28/2011
Abstract: Background. Short- and long-term data showed that drug-eluting stents (DES) significantly decreased target vessel revascularization (TVR) and major adverse cardiac event (MACE) rates compared to bare-metal stents (BMS). However,...
Abstract: Background. Short- and long-term data showed that drug-eluting stents (DES) significantly decreased target vessel revascularization (TVR) and major adverse cardiac event (MACE) rates compared to bare-metal stents (BMS). However,...
Abstract: Background. Short- and...
07/28/2011
Journal of Invasive Cardiology